The Purpose of This Study is to Evaluate the Spirometric Effect (Trough FEV1) of Umeclidinium/Vilanterol 62.5/25 mcg Once Daily Compared With Tiotriopium 18 mcg Once Daily Over a 24-week Treatment Period in Subjects With COPD

GSK Investigational Site, Budaörs

GSK Investigational Site, Gödöllő

GSK Investigational Site, Balassagyarmat

GSK Investigational Site, Szikszó

GSK Investigational Site, Plovdiv

GSK Investigational Site, Debrecen

GSK Investigational Site, Nyíregyháza

GSK Investigational Site, Troyan Municipality

GSK Investigational Site, Pleven

GSK Investigational Site, Stara Zagora

GSK Investigational Site, Dimitrovgrad

GSK Investigational Site, Rousse

GSK Investigational Site, Varna

GSK Investigational Site, Berlin

GSK Investigational Site, Berlin

GSK Investigational Site, Berlin

GSK Investigational Site, Salt (gerona)

GSK Investigational Site, Hamburg

GSK Investigational Site, Geesthacht

GSK Investigational Site, Spartanburg

GSK Investigational Site, Gaffney

GSK Investigational Site, Union

GSK Investigational Site, Greenville

GSK Investigational Site, Easley

GSK Investigational Site, Rock Hill

GSK Investigational Site, Panama City

GSK Investigational Site, DeLand

GSK Investigational Site, Johnson City

GSK Investigational Site, Columbus

GSK Investigational Site, Valencia

GSK Investigational Site, Frankfurt am Main

GSK Investigational Site, Neu-Isenburg

GSK Investigational Site, Saint Charles

GSK Investigational Site, Omaha

GSK Investigational Site, Bucharest

GSK Investigational Site, Coeur d'Alene

GSK Investigational Site, Tucson

GSK Investigational Site, Riverside

GSK Investigational Site, Moscow

GSK Investigational Site, Moscow

GSK Investigational Site, Saint Petersburg

GSK Investigational Site, Saint Petersburg

GSK Investigational Site, Belgorod

GSK Investigational Site, Deva

GSK Investigational Site, Krasnodar

GSK Investigational Site, Pyatigorsk

GSK Investigational Site, Cluj-Napoca

GSK Investigational Site, Codlea

GSK Investigational Site, San Diego

GSK Investigational Site, Charleston

GSK Investigational Site, Ciudad Autnónoma de Buenos Aires

GSK Investigational Site, Vancouver

GSK Investigational Site, Moncton

GSK Investigational Site, Burlington

GSK Investigational Site, Hamilton

GSK Investigational Site, Toronto

GSK Investigational Site, Toronto

GSK Investigational Site, Toronto

GSK Investigational Site, Montreal

GSK Investigational Site, Québec

GSK Investigational Site, Saint-Charles-Borromée

GSK Investigational Site, Sherbrooke

GSK Investigational Site, Dresden

GSK Investigational Site, Leipzig

GSK Investigational Site, Leipzig

GSK Investigational Site, Bucharest

GSK Investigational Site, Bucharest

GSK Investigational Site, Barnaul

GSK Investigational Site, Alicante

GSK Investigational Site, Mérida (Badajoz)